STALEY CAPITAL ADVISERS’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $367K | Hold |
1,976
| – | – | 0.02% | 149 |
|
|
2025
Q1 | $414K | Hold |
1,976
| – | – | 0.02% | 146 |
|
|
2024
Q4 | $351K | Hold |
1,976
| – | – | 0.02% | 150 |
|
|
2024
Q3 | $390K | Hold |
1,976
| – | – | 0.02% | 148 |
|
|
2024
Q2 | $339K | Buy |
1,976
+81
| +4% | +$13.9K | 0.02% | 152 |
|
|
2024
Q1 | $345K | Hold |
1,895
| – | – | 0.02% | 149 |
|
|
2023
Q4 | $294K | Sell |
1,895
-600
| -24% | -$93K | 0.01% | 152 |
|
|
2023
Q3 | $372K | Sell |
2,495
-260
| -9% | -$38.8K | 0.02% | 139 |
|
|
2023
Q2 | $371K | Buy |
2,755
+12
| +0.4% | +$1.62K | 0.02% | 142 |
|
|
2023
Q1 | $437K | Hold |
2,743
| – | – | 0.02% | 133 |
|
|
2022
Q4 | $443K | Hold |
2,743
| – | – | 0.03% | 119 |
|
|
2022
Q3 | $368K | Buy |
2,743
+281
| +11% | +$37.7K | 0.02% | 126 |
|
|
2022
Q2 | $377K | Hold |
2,462
| – | – | 0.02% | 124 |
|
|
2022
Q1 | $399K | Sell |
2,462
-500
| -17% | -$81K | 0.02% | 133 |
|
|
2021
Q4 | $401K | Hold |
2,962
| – | – | 0.02% | 137 |
|
|
2021
Q3 | $320K | Sell |
2,962
-300
| -9% | -$32.4K | 0.02% | 146 |
|
|
2021
Q2 | $367K | Sell |
3,262
-150
| -4% | -$16.9K | 0.02% | 141 |
|
|
2021
Q1 | $369K | Buy |
3,412
+150
| +5% | +$16.2K | 0.02% | 140 |
|
|
2020
Q4 | $350K | Buy |
3,262
+500
| +18% | +$53.6K | 0.02% | 137 |
|
|
2020
Q3 | $242K | Hold |
2,762
| – | – | 0.02% | 146 |
|
|
2020
Q2 | $271K | Buy |
+2,762
| New | +$271K | 0.02% | 133 |
|